First Time Loading...
S

Singular Genomics Systems Inc
NASDAQ:OMIC

Watchlist Manager
Singular Genomics Systems Inc
NASDAQ:OMIC
Watchlist
Price: 0.4 USD -1.74% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

OMIC Price Targets Summary
Singular Genomics Systems Inc

Wall Street analysts forecast OMIC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OMIC is 0.87 USD with a low forecast of 0.86 USD and a high forecast of 0.89 USD.

OMIC Lowest Forecast
Wall Street Target
0.86 USD
115% Upside
OMIC Average Forecast
Wall Street Target
0.87 USD
117% Upside
OMIC Highest Forecast
Wall Street Target
0.89 USD
123% Upside
Lowest
Price Target
0.86 USD
115% Upside
Average
Price Target
0.87 USD
117% Upside
Highest
Price Target
0.89 USD
123% Upside
Singular Genomics Systems Inc Competitors:
Price Targets
DXRX
Diaceutics PLC
71% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
Q
QSI
Quantum-Si Inc
59% Upside
CRL
Charles River Laboratories International Inc
20% Upside
DXRX
Diaceutics PLC
71% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
Q
QSI
Quantum-Si Inc
59% Upside
CRL
Charles River Laboratories International Inc
20% Upside
HVO
hVIVO PLC
32% Upside
MTD
Mettler-Toledo International Inc
0% Downside
CHEMM
Chemometec A/S
63% Upside
ERGO
Ergomed PLC
7% Upside

Revenue
Forecast

Revenue Estimate
Singular Genomics Systems Inc

The compound annual growth rate of Singular Genomics Systems Inc's revenue for the next 3 years is 132%.

N/A
Past Growth
132%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Singular Genomics Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Singular Genomics Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
OMIC intrinsic value, competitors valuation, and company profile.
DCF Valuation
OMIC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OMIC stock valuation using valuation multiples.
Wall Street Estimates
OMIC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OMIC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OMIC's stock price target?
Price Target
0.87 USD

According to Wall Street analysts, the average 1-year price target for OMIC is 0.87 USD with a low forecast of 0.86 USD and a high forecast of 0.89 USD.

What is Singular Genomics Systems Inc's Revenue forecast?
Projected CAGR
132%

The compound annual growth rate of Singular Genomics Systems Inc's revenue for the next 3 years is 132%.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.